A prospective randomised open label study to determine the best dose escalation scheme of dipyridamol added to acetylsalicylic acid, based on the side-effect headache, in patients starting secondary preventive therapy for stroke

Completed

• Conditions: CVA / TIA; Stroke; 10029305

• Registration Number: NL-OMON36298
• Lead Sponsor: Albert Schweitzer Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 114

Inclusion Criteria

age over 18
CVA or TIA
Patients starting treatment with acetylsalicylic acid combined with dipyridamole according to Dutch treatment standards

Exclusion Criteria

Patients not able to start treatment with acetylsalicylic acid combined with dipyridamole according to Dutch treatment standards

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Headache frequency</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>